Brief: Cansino Biologics's Net Loss Narrows In H1
29/08/2024 11:10
Aug 29 (Reuters) - Cansino Biologics 688185.SS :
* SAYS NET LOSS NARROWS TO 225.4 MILLION YUAN ($31.77
million) IN
H1
Source text
Further company coverage: 688185.SS
($1 = 7.0937 Chinese yuan renminbi)
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025